Home PTC Therapeutics Announces Expanded Access Program For Translarna (Ataluren)
 

Keywords :   


PTC Therapeutics Announces Expanded Access Program For Translarna (Ataluren)

2014-07-30 10:38:53| drugdiscoveryonline Home Page

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the initiation of a reimbursed expanded access program (EAP). PTC's EAP program is intended to make Translarna™ (ataluren) available to patients before commercial availability in certain countries

Tags: program access expanded announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
More »